Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDV-HUJ in Advanced Glioblastoma, Sarcoma, and Neuroblastoma
NCT01174537Phase 2Withdrawn
- Sponsor
- Hadassah Medical Organization
- Start
- Jul 2011
- Primary completion
- Jul 2011
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of newcastle disease virus in glioblastoma (GBM), sarcoma, neuroblastoma, sponsored by Hadassah Medical Organization. Planned start Jul 2011; status: withdrawn.
02
Drugs
newcastle disease virus
03
Conditions
glioblastoma (GBM)sarcomaneuroblastoma
Beyond the preview
Go deeper on NCT01174537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174537.